Additionally, inhibiting PDI with either an inhibitor or an antibody has demonstrated therapeutic effects in thromboinflammatory conditions and other cardiovascular diseases, supported by both basic research and clinical trials [14, 15]. This evidence concerns the gene P4HB and cardiovascular disorder.